Black Diamond Therapeutics announces CEO change; stock falls
18/09/2023 15:21
** Shares of precision oncology firm Black Diamond
Therapeutics BDTX.O down 6.8% at $3.30
** Company appoints current chairman of board, Mark Velleca,
as its chief executive officer
** Velleca succeeds CEO and co-founder, David Epstein, who
has stepped down and will continue to serve on the board
** Including sessions losses, stock up 88% YTD
(Reporting by Judes Joseph in Bengaluru)
((judes.joseph@thomsonreuters.com;))